Pipeline

Overview

	Pre-clinical	IND	Phase 1	Phase 2	Phase 3	Approved
Type 2 Diabetes
VRS-859 (Exenatide)
AMX-808 (Combination with VRS-859)
VRS-826 (IL-1ra)
Growth Deficiency
VRS-317 (hGH)